Moreover, it is surprising that many ABT-SLCs are not identified by contemporary in silico studies of selection in cancer [6, 28, 56], given that germline ABT-SLC SNPs can increase cancer risk [20, 95] and genetic ablation of ABT-SLCs substantially impairs cancer cell fitness in vitro [4, 60]. This evidence concerns the gene CCL21 and cancer.